Dice Therapeutics Inc (DICE) Earnings Report, Financial Results, Financial analysis

Dice Therapeutics Inc reported IV. Quarter net loss per share of $-0.31 compare to earnings per share of $0.59 in the same quarter a year ago and improved compare to net loss per share of $-0.55 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.31	$ 0 Mill
$-0.90	Unch.

Dice Therapeutics Inc 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Dice Therapeutics Inc is Expected to report next financial results on May 11, 2023.

More on DICE's Income Statement

DICE's NET INCOME

Dice Therapeutics Inc 's in IV. Quarter recorded net loss of $-23.224 million, compare to net income of $17.335 million achieved in IV. Quarter a year ago.

Sequentially net loss advanced

More on DICE's Growth

Dice Therapeutics Inc Inventories
DICE's Cash flow In IV. Quarter company's net cash flow was $413 million, capital expenditures fell by 122.96%, to $0 millions compare to same quarter a year ago and rose by -16.60% from III. Quarter (Sep 30 2022).

More on DICE's Cash flow Statement

Earnings quality

Dice Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Dice Therapeutics Inc payed $ -1.63 cash per share, on a free-cash flow basis .

Book value grew by 106.65 % sequentially to $14.40 per share.
Tangible Book value grew to $ 14.40 per share from $ 6.97.

Company issued 1.90 million shares or 5.08 % in IV. Quarter.

• More on DICE's Dividends

Market Capitalization (Millions)	1,128
Shares Outstanding (Millions)	39
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-84
Cash Flow (TTM) (Millions $)	345
Capital Exp. (TTM) (Millions $)	-2
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Dice Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Dice Therapeutics Inc had negative $ -1.63 cash flow per share, on a free-cash flow basis .

Book value grew by 106.65 % sequentially to $14.40 per share.
Tangible Book value grew to $ 14.40 per share from $ 6.97.

Company issued 1.90 million shares or 5.08 % in IV. Quarter.

• More on DICE's Balance Sheets

Market Capitalization (Millions)	1,128
Shares Outstanding (Millions)	39
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	-
Net Income (TTM) (Millions $)	-84
Cash Flow (TTM) (Millions $)	345
Capital Exp. (TTM) (Millions $)	-2
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar GAMB's Profile Stock Price GAMB's Financials Business Description Fundamentals Charts & Quotes GAMB's News Suppliers GAMB's Competitors Customers & Markets Economic Indicators GAMB's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Dice Therapeutics Inc

DICE's Financial Statements and Analysis